Valiant Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	70.56	49.17	117.18	12.62	1.31
Short-Term Investments	260.94	714.79	1,321	340.99	-
Cash & Short-Term Investments	331.5	763.96	1,438	353.6	1.31
Cash Growth	-56.61%	-46.88%	306.74%	26830.85%	-
Accounts Receivable	935.65	721.22	457.27	885.68	1,108
Other Receivables	16.84	2.51	18.74	7.22	0.08
Receivables	952.91	724.34	476.31	893.61	1,108
Inventory	454.26	39.89	100.15	130.42	158.04
Prepaid Expenses	-	1.51	1.44	5.19	1.52
Other Current Assets	544.57	396.48	239.3	122.96	228.56
Total Current Assets	2,283	1,926	2,255	1,506	1,497
Property, Plant & Equipment	2,331	2,041	927.03	487.98	236.72
Long-Term Investments	-	-	-	-	4.02
Other Intangible Assets	1.12	1.08	-	-	-
Other Long-Term Assets	24.43	40.22	244.41	135.89	6.1
Total Assets	4,640	4,009	3,427	2,130	1,744
Accounts Payable	940.25	407.16	259.27	472.96	397.24
Accrued Expenses	-	18.11	12.39	19.05	-
Short-Term Debt	168.56	168.56	13.88	-	-
Current Portion of Long-Term Debt	-	-	-	-	12.81
Current Portion of Leases	4.66	2.31	2.31	1.75	1.78
Other Current Liabilities	81	0.02	2.92	13.49	8.37
Total Current Liabilities	1,194	596.16	290.77	507.26	420.21
Long-Term Debt	280.93	1,043	746.63	594	594
Long-Term Leases	7.98	2.51	4.27	6.42	2.67
Long-Term Deferred Tax Liabilities	36.48	12.42	6.18	6.66	2.96
Other Long-Term Liabilities	11.07	10.9	10.42	10.4	9.61
Total Liabilities	1,531	1,665	1,058	1,125	1,029
Common Stock	543.13	434.5	434.5	325.6	162.8
Additional Paid-In Capital	-	1,410	1,413	163.39	-
Retained Earnings	-	498.81	520.87	515.92	-
Comprehensive Income & Other	2,566	-0.19	-	-	551.8
Shareholders' Equity	3,109	2,343	2,369	1,005	714.6
Total Liabilities & Equity	4,640	4,009	3,427	2,130	1,744
Total Debt	462.12	1,217	767.08	602.18	611.26
Net Cash (Debt)	-130.62	-452.91	671.15	-248.58	-609.95
Net Cash Per Share	-2.04	-10.42	17.66	-7.63	-18.73
Filing Date Shares Outstanding	54.96	43.45	43.45	32.56	32.56
Total Common Shares Outstanding	54.96	43.45	43.45	32.56	32.56
Working Capital	1,089	1,330	1,965	998.52	1,077
Book Value Per Share	56.57	53.93	54.51	30.86	21.95
Tangible Book Value	3,108	2,342	2,369	1,005	714.6
Tangible Book Value Per Share	56.55	53.90	54.51	30.86	21.95
Land	-	226.48	226.48	226.48	-
Buildings	-	122.29	121.99	120.09	95.24
Machinery	-	341.29	338.37	301.26	147.47
Construction In Progress	-	1,558	426.49	6.8	14.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.